tiprankstipranks
Nexalin Technology regains compliance with Nasdaq continued listing rules
PremiumThe FlyNexalin Technology regains compliance with Nasdaq continued listing rules
2M ago
Nexalin announces study on AD, DIFS published in Journal of Alzheimer’s Disease
Premium
The Fly
Nexalin announces study on AD, DIFS published in Journal of Alzheimer’s Disease
2M ago
Nexalin announced planned clinical trial utilizing Gen-3 Halo headset
Premium
The Fly
Nexalin announced planned clinical trial utilizing Gen-3 Halo headset
2M ago
Nexalin Technology participates in Congressional roundtable
PremiumThe FlyNexalin Technology participates in Congressional roundtable
4M ago
Nexalin Technology SVP Michael Nketiah Announces Resignation
Premium
Company Announcements
Nexalin Technology SVP Michael Nketiah Announces Resignation
5M ago
Nexalin selected to join Breaking Barriers to Substance Use Recovery coalition
Premium
The Fly
Nexalin selected to join Breaking Barriers to Substance Use Recovery coalition
5M ago
Nexalin Technology announces Brazilian regulatory approval to sell Gen-2 device
PremiumThe FlyNexalin Technology announces Brazilian regulatory approval to sell Gen-2 device
6M ago
Nexalin Technology says FDA reaches consensus on design for HALO studies
Premium
The Fly
Nexalin Technology says FDA reaches consensus on design for HALO studies
7M ago
Nexalin Technology files to sell $7M of common stock
Premium
The Fly
Nexalin Technology files to sell $7M of common stock
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100